If his mother hadn’t struck up a conversation with a stranger in a waiting room, Dan Shapiro would never have become the biological father of Alexandra, 13, and Abigail, 9. Dan was a 20-year-old junior in college when doctors diagnosed stage 2 Hodgkin’s disease. His treatment was to be six cycles of highly toxic chemotherapy followed by radiation.
He and his mother were waiting in the doctor’s office to discuss therapy when his mother began chatting with a woman whose 14-year-old son was being treated for leukemia, Shapiro, now 42 and a professor at Penn State College of Medicine, recounts in his delightful book, Mom’s Marijuana (Harmony Books, 2000).
“Has he banked sperm?” the woman asked Mrs Shapiro. “He should bank sperm. I had my son do it.” To which Mrs Shapiro replied, “I didn’t realize the treatment would make him sterile; the doctors haven’t said anything.”
At Mrs Shapiro’s insistence, Dan’s treatment was delayed long enough for him to bank sperm, which for a few hundred US dollars a year was kept frozen until he was ready to start a family nine years later.
A NEGLECTED ISSUE
Although more attention is now paid to loss of fertility among cancer patients, it is still too often overlooked by oncologists and patients, who may survive their disease but be left unable to reproduce. Neglect of fertility issues is especially common in cases involving children yet to reach puberty.
Yet in guidelines issued nearly three years ago, the American Society of Clinical Oncology stated that “any oncologist seeing reproductive-aged patients for consideration of cancer therapy should be addressing potential treatment-related infertility with them or, in the case of children, with their parents.” The guidelines noted that “sperm and embryo cryopreservation are considered standard practice and are widely available.”
What often happens instead is that patients, who are naturally terrified by the diagnosis and focused on survival, fail to ask whether treatment will leave them infertile. And oncologists, who are focused on beginning effective treatment as soon as possible, fail to consider the effects on their patients’ future fertility.
The University of North Carolina’s Fertility Preservation Program estimates that only a quarter of oncologists nationwide address fertility issues with patients before treatment begins.
In December 2007, Margaret Kresge Poe of Atlanta was 32 and getting ready to start a family with her husband when she was shocked to discover that what she thought were hemorrhoids was stage 3 rectal cancer. The proposed treatment — surgery, chemotherapy and pelvic radiation — would have left her unable to bear children, yet the doctor never mentioned an effect on her fertility.
“It was family members who raised the issue,” Poe said in an interview. “At the time, I could barely think straight.”
Her treatment was delayed long enough to harvest eggs and have them fertilized and frozen as embryos, and Poe entered a clinical trial that used aggressive chemotherapy but none of the organ-damaging radiation that would have left her infertile.
“Hopefully,” Poe said, “we’ll have those embryos as real children before long.”
Each year, an estimated 16,000 women younger than 45 find out they have breast cancer, according to a report in February in the New England Journal of Medicine.
“Many of these young women were planning to have children or contemplating the possibility,” Jacqueline Jeruss and Teresa Woodruff of Northwestern University Feinberg School of Medicine wrote in the journal. “In some, but not all patients, options for the preservation of fertility can be explored before the initiation of therapy.”
Complicating matters is the fact that health insurance policies may not cover fertility treatments for women about to be treated for cancer, and out-of-pocket costs for harvesting eggs, creating embryos and having in vitro fertilization can reach tens of thousands of US dollars. Timing is another obstacle; it can take months to secure an appointment at a fertility clinic, and cancer patients cannot wait so long before starting treatment.
FASTER FERTILITY SERVICE
The National Institutes of Health is financing a new program, the Oncofertility Consortium, to help cancer patients concerned about preserving their fertility. The consortium, at myoncofertility.org, is led by the Northwestern researchers and seeks to foster wider attention to and better options for fertility preservation in young cancer patients. Participating health professionals are pursuing technologies to improve fertility options for cancer patients and helping those patients gain access to fertility help.
“Now at 50 sites throughout the country, there are local or regional resources where fertility issues can be taken care of quickly, with minimal delay to starting cancer treatment,” Woodruff, a professor of obstetrics and gynecology, said in an interview.
“Women who want to harvest eggs and store embryos can be treated often within a week instead of having to wait months, as typically happens at fertility clinics,” she said.
One young patient helped by the consortium was a 16-year-old girl from Southern California who was about to refuse cancer treatment after learning it would leave her sterile. All told, Woodruff said, “about 140,000 cancer patients each year should be told if treatment will damage their fertility and presented with options if this is a concern to them.”
Among patients who consult consortium participants, “about one-quarter don’t choose fertility-preserving options,” she said, “but this decision should be based on up-to-date information about a comprehensive set of options and the ability to act quickly.”
OPTIONS FOR MEN AND CHILDREN
For men with cancer, the solution is usually simple and involves little delay: a visit to a sperm bank where a semen sample can be obtained. Sperm can be frozen and stored, remaining able to fertilize an egg for up to 28 years and perhaps longer. Even men who have no sperm in their ejaculate can sometimes undergo a testicular biopsy to isolate sperm, the Northwestern experts said.
Children’s cancers are typically treated with highly toxic chemotherapy and often radiation that threatens their future fertility. Yet, the journal authors wrote, “Children with cancer and their families have not typically been offered options for fertility preservation.”
Before treatment, boys who have gone through puberty can provide semen samples through masturbation, electroejaculation or surgical sperm extraction. For younger boys, research is under way to see whether freezing sperm-forming stem cells will preserve their future fertility.
Adolescent girls facing the prospect of pelvic radiation can have their ovaries moved temporarily outside the radiation field. Or ovarian tissue can be removed and frozen in hopes that research now being pursued will one day allow viable eggs to be developed in the laboratory.
Common sense is not that common: a recent study from the University of Pennsylvania concludes the concept is “somewhat illusory.” Researchers collected statements from various sources that had been described as “common sense” and put them to test subjects. The mixed bag of results suggested there was “little evidence that more than a small fraction of beliefs is common to more than a small fraction of people.” It’s no surprise that there are few universally shared notions of what stands to reason. People took a horse worming drug to cure COVID! They think low-traffic neighborhoods are a communist plot and call
Taiwan, once relegated to the backwaters of international news media and viewed as a subset topic of “greater China,” is now a hot topic. Words associated with Taiwan include “invasion,” “contingency” and, on the more cheerful side, “semiconductors” and “tourism.” It is worth noting that while Taiwanese companies play important roles in the semiconductor industry, there is no such thing as a “Taiwan semiconductor” or a “Taiwan chip.” If crucial suppliers are included, the supply chain is in the thousands and spans the globe. Both of the variants of the so-called “silicon shield” are pure fantasy. There are four primary drivers
The sprawling port city of Kaohsiung seldom wins plaudits for its beauty or architectural history. That said, like any other metropolis of its size, it does have a number of strange or striking buildings. This article describes a few such curiosities, all but one of which I stumbled across by accident. BOMBPROOF HANGARS Just north of Kaohsiung International Airport, hidden among houses and small apartment buildings that look as though they were built between 15 and 30 years ago, are two mysterious bunker-like structures that date from the airport’s establishment as a Japanese base during World War II. Each is just about
The female body is a horror movie waiting to happen. From puberty and the grisly onset of menstruation, in pictures such as Brian De Palma’s Carrie and John Fawcett’s Ginger Snaps, to pregnancy and childbirth — Rosemary’s Baby is the obvious example — women have provided a rich seam of inspiration for genre film-makers over the past half century. But look a little closer and two trends become apparent: the vast majority of female body-based horror deals with various aspects of the reproductive system, and it has largely been made by men (Titane and The First Omen, two recent examples
RSS